Video Experimental Relacionado
Updated: Jun 22, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Enfermedad de Parkinson enfermedad de Parkinson
Andrew J Lees1, John Hardy, Tamas Revesz
1Department of Molecular Neuroscience and Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London and the National Hospital for Neurology and Neurosurgery, London, UK. alees@ion.ucl.ac.uk
Lancet (London, England)
|June 16, 2009
Resumen
La enfermedad de Parkinson, un trastorno neurodegenerativo común, implica la pérdida de células cerebrales y la acumulación de alfa-sinucleína. Los tratamientos manejan los síntomas motores y mejoran la calidad de vida, con células madre y terapia génica que muestran una promesa futura.
Área de la Ciencia:
- Neurología Neurología.
- La neurociencia es la neurociencia.
- Genética La genética.
Sus antecedentes:
- La enfermedad de Parkinson es un trastorno bradikinético progresivo.
- Las principales características patológicas incluyen la pérdida de células negras y la agregación de alfa-sinucleína.
- La edad es el principal factor de riesgo, y la predisposición genética también juega un papel importante.
Objetivo del estudio:
- Para resumir las características clave, los factores de riesgo y los enfoques terapéuticos para la enfermedad de Parkinson.
- Para resaltar la precisión del diagnóstico y la base patológica del trastorno.
- Para discutir las estrategias de tratamiento actuales y emergentes.
Principales métodos:
- Revisión de la literatura existente sobre la patología de la enfermedad de Parkinson y la presentación clínica.
- Análisis de los factores genéticos que contribuyen a la susceptibilidad a las enfermedades.
- Evaluación de las actuales intervenciones terapéuticas y las futuras direcciones de investigación.
Principales resultados:
- La enfermedad de Parkinson se caracteriza por cambios neuropatológicos específicos.
- La edad y los factores genéticos (por ejemplo, LRRK-2, GBA) son cruciales en el desarrollo de la enfermedad.
- La terapia de reemplazo de dopamina y el manejo de los síntomas no motores mejoran los resultados de los pacientes.
Conclusiones:
- Es posible lograr un diagnóstico preciso de la enfermedad de Parkinson.
- Comprender la susceptibilidad genética es vital para la investigación de la enfermedad de Parkinson.
- Las terapias emergentes como las células madre y la terapia génica ofrecen potencial para futuros tratamientos.
Videos de Conceptos Relacionados
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...